FDA Grants Breakthrough Designation to VT Ablation System
The pulsed field ablation technology for ventricular tachycardia has been granted FDA Breakthrough Device Designation and accepted into the TAP pilot program.
The pulsed field ablation technology for ventricular tachycardia has been granted FDA Breakthrough Device Designation and accepted into the TAP pilot program.
Women with atrial fibrillation undergoing a procedure called pulsed field ablation have just as good outcomes as men, a new study finds.